Related Experiment Videos
Continuous venovenous hemofiltration: a cost-effective therapy for the pediatric patient
C M Gilman1, B E Coffel, S K Gunn
1Riley Hospital for Children, Indiana University Medical Center, Indianapolis, USA.
Insights
Continuous venovenous hemofiltration (CVVH) is surprisingly cost-effective for critically ill children, representing a small part of total hospital costs. This life-saving treatment offers better survival chances without significantly increasing overall expenses.
Area of Science:
- Pediatric Critical Care Medicine
- Health Economics
Background:
- Continuous venovenous hemofiltration (CVVH) is an intensive treatment for critically ill children.
- The cost-effectiveness of CVVH in pediatric populations has been a concern.
Purpose of the Study:
- To evaluate the cost-effectiveness of CVVH in pediatric patients.
- To determine the proportion of total admission costs attributed to CVVH.
Main Methods:
- Retrospective analysis of patient data at Riley Hospital for Children.
- Calculation of CVVH costs as a fraction of total inpatient admission costs.
Main Results:
- CVVH costs represent a small fraction of total admission costs, even for prolonged treatment durations.
- The cost of CVVH does not lead to an extraordinary increase in overall hospital bills.
Conclusions:
- CVVH is a cost-effective intervention for critically ill children, offering a chance at survival.
- Further research is recommended on patient selection, treatment timing, and outcome improvement for CVVH.
Abstract:
The authors were surprised to discover that at Riley Hospital for Children the cost of continuous venovenous hemofiltration (CVVH) constitutes a small fraction of the total admission costs, even when it is performed for a large portion of inpatient stays. A reasonable treatment that gives critically ill children reasonable chances of surviving at reasonable costs, must be considered cost-effective. CVVH currently offers some pediatric patients an additional chance at survival without an extraordinary increase in total hospital bills. Further research regarding patient selection, timing of initiation of therapy, and improving outcomes is recommended.